Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Noriaki, Arakawa"'
Autor:
Gaku Yamamichi, Taigo Kato, Noriaki Arakawa, Yoko Ino, Takeshi Ujike, Kosuke Nakano, Yoko Koh, Yuichi Motoyama, Hidetatsu Outani, Shohei Myoba, Yu Ishizuya, Yoshiyuki Yamamoto, Koji Hatano, Atsunari Kawashima, Shinichiro Fukuhara, Hiroji Uemura, Seiji Okada, Eiichi Morii, Norio Nonomura, Motohide Uemura
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-20 (2024)
Abstract Background Bone metastasis (BM) is a common and fatal condition in patients with castration-resistant prostate cancer (CRPC). However, there are no useful blood biomarkers for CRPC with BM, and the mechanism underlying BM is unclear. In this
Externí odkaz:
https://doaj.org/article/a5c86740f5214628a1483d9bc5b52328
Autor:
Noriko Sakuma, Mitsuhiro Abe, Daisuke Ishii, Takeshi Kawasaki, Noriaki Arakawa, Shinichiro Matsuyama, Yoshiro Saito, Takuji Suzuki, Koichiro Tatsumi
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Serum levels of stratifin (SFN), a member of the 14-3-3 protein family, increase in patients with drug-induced lung injury associated with diffuse alveolar damage. Therefore, we hypothesised that SFN levels would be higher in thos
Externí odkaz:
https://doaj.org/article/eaca6bc8b07c47b08d99190d4292e37c
Autor:
Yuchen Sun, Kosuke Saito, Atsuhito Ushiki, Mitsuhiro Abe, Yoshinobu Saito, Takeru Kashiwada, Yasushi Horimasu, Akihiko Gemma, Koichiro Tatsumi, Noboru Hattori, Kenji Tsushima, Kazuhisa Takemoto, Rika Ishikawa, Toshiko Momiyama, Shin-ichiro Matsuyama, Noriaki Arakawa, Hirotoshi Akane, Takeshi Toyoda, Kumiko Ogawa, Motonobu Sato, Kazuhiko Takamatsu, Kazuhiko Mori, Takayoshi Nishiya, Takashi Izumi, Yasuo Ohno, Yoshiro Saito, Masayuki Hanaoka
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-23 (2024)
Abstract Background Drug-induced interstitial lung disease (DILD) is a lung injury caused by various types of drugs and is a serious problem in both clinical practice and drug development. Clinical management of the condition would be improved if the
Externí odkaz:
https://doaj.org/article/1318948710974ad7a181c0d83d189e4d
Autor:
Kosuke Saito, Akihiko Gemma, Koichiro Tatsumi, Noboru Hattori, Atsuhito Ushiki, Kenji Tsushima, Yoshinobu Saito, Mitsuhiro Abe, Yasushi Horimasu, Takeru Kashiwada, Kazuhiko Mori, Motonobu Sato, Takayoshi Nishiya, Kazuhiko Takamatsu, Yuchen Sun, Noriaki Arakawa, Takashi Izumi, Yasuo Ohno, Yoshiro Saito, Masayuki Hanaoka
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Drug-induced interstitial lung disease (DILD) occurs when drug exposure causes inflammation of the lung interstitium. DILD can be caused by different types of drugs, and some DILD patterns results in a high mortality rate; hence, DILD poses
Externí odkaz:
https://doaj.org/article/0c7f20c00a684773a7c25ae7391cf65d
Autor:
Noriaki Arakawa, Atsuhito Ushiki, Mitsuhiro Abe, Shinichiro Matsuyama, Yoshinobu Saito, Takeru Kashiwada, Yasushi Horimasu, Akihiko Gemma, Koichiro Tatsumi, Noboru Hattori, Kenji Tsushima, Keiko Miyashita, Kosuke Saito, Ryosuke Nakamura, Takeshi Toyoda, Kumiko Ogawa, Motonobu Sato, Kazuhiko Takamatsu, Kazuhiko Mori, Takayoshi Nishiya, Takashi Izumi, Yasuo Ohno, Yoshiro Saito, Masayuki Hanaoka
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
No reliable serum biomarker for diffuse alveolar damage, a poor prognosis subtype of drug-induced interstitial lung disease, is currently available. Here, the authors show stratifin/14-3-3σ in serum is a promising biomarker for diagnosis of this typ
Externí odkaz:
https://doaj.org/article/26c767ba6b984eb3ba31e8f03b45e8ce
Autor:
Kosuke Saito, Rika Ishikawa, Isao Kitamura, Kumiko Ogawa, Noriaki Arakawa, Yuchen Sun, Kazuo Imai, Takuya Maeda, Yoshiro Saito, Chihiro Hasegawa
Publikováno v:
Journal of Pharmacological Sciences, Vol 150, Iss 2, Pp 49-55 (2022)
The coronavirus disease 2019 (COVID-19) pandemic has been associated with high mortality worldwide. Owing to its complicated pathophysiology, diagnostic and prognostic biomarkers for effective patient management remain scarce. We analyzed kynurenine,
Externí odkaz:
https://doaj.org/article/1a72e057b07643b1ac22799639a56ac4
Autor:
Noriaki Arakawa, Shinichiro Matsuyama, Masaru Matsuoka, Isao Kitamura, Keiko Miyashita, Yutaro Kitagawa, Kazuo Imai, Kumiko Ogawa, Takuya Maeda, Yoshiro Saito, Chihiro Hasegawa
Publikováno v:
Journal of Pharmacological Sciences, Vol 150, Iss 1, Pp 21-30 (2022)
The prognosis of patients with severe cases of COVID-19 is poor; thus, biomarkers for earlier prediction of COVID-19 progression are vital. We measured levels of five lung injury-related biomarkers, SP-D, KL-6, presepsin, kallistatin and stratifin, i
Externí odkaz:
https://doaj.org/article/950290dd22614200abf2e6e6d3336397
Autor:
Kazuo Imai, Masaru Matsuoka, Sakiko Tabata, Yutaro Kitagawa, Mayu Nagura-Ikeda, Katsumi Kubota, Ai Fukada, Tomohito Takada, Momoko Sato, Sakiko Noguchi, Shinichi Takeuchi, Noriaki Arakawa, Kazuyasu Miyoshi, Yoshiro Saito, Takuya Maeda
Publikováno v:
International Journal of Infectious Diseases, Vol 111, Iss , Pp 68-75 (2021)
Background: The cross-reactive antibody response against seasonal human coronaviruses (HCoVs) was evaluated according to disease severity in patients with COVID-19 in Japan.Methods: In total, 194 paired serum samples collected from 97 patients with C
Externí odkaz:
https://doaj.org/article/c57b037038a9419dab3bfcbbfcd4433d
Publikováno v:
Data in Brief, Vol 7, Iss , Pp 1302-1305 (2016)
We present data obtained using a focused proteomics approach to identify the glycosylphosphatidylinositol (GPI)-anchored peptides in 19 human cancer cell lines. GPI-anchored proteins (GPI-APs), which localize to the outer leaflet of the membrane micr
Externí odkaz:
https://doaj.org/article/70ac8fa1411e44898cc1e9ff791775d9
Autor:
Kosuke Saito, Tatehiro Kagawa, Keiji Tsuji, Yuji Kumagai, Ken Sato, Shotaro Sakisaka, Naoya Sakamoto, Mitsuhiko Aiso, Shunji Hirose, Nami Mori, Rieko Tanaka, Toshio Uraoka, Kazuhide Takata, Koji Ogawa, Kazuhiko Mori, Motonobu Sato, Takayoshi Nishiya, Kazuhiko Takamatsu, Noriaki Arakawa, Takashi Izumi, Yasuo Ohno, Yoshiro Saito, Hajime Takikawa
Publikováno v:
Metabolites, Vol 10, Iss 9, p 355 (2020)
Drug-induced liver injury (DILI) is a major adverse event caused by drug treatment, which can be categorized into three types: hepatocellular, mixed, and cholestatic. Although nearly every class of drugs can cause DILI, an overall understanding of li
Externí odkaz:
https://doaj.org/article/fb4ff2dbe5c84f8e8d0740efbb71510a